Literature DB >> 21735817

[Cytosine methylation in DNA and its role in cancer therapy].

Beata Plitta1, Małgorzata Giel-Pietraszuk, Wojciech T Markiewicz, Jan Barciszewski.   

Abstract

DNA methyltransferase 1 (DNMT1) is one of three enzymes independently coded in mammalian cells. It catalyses postreplicative synthesis of 5-methylcytosine in DNA. The aim of this modification is regulation of gene expression characteristic for the given organism. DNMT1 maintains methylation pattern by copying it from maternal to daughter stand. S-adenosylo-L-methionina is a donor of methyl group in his process. Disturbance in methylation level results in changes in cell differentiation and finally to tumor transformation. Hypermethylation of promotor or first exon of tumor suppression gene results in silencing of its transcription. While hypomethylation of regulatory sequence of protooncogene and retrotransposon make them transcriptionally active. DNMT1 as a key enzyme in maintaing of proper methylation pattern is a attractive target in anti-tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735817

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  2 in total

1.  In silico analysis of CpG islands and miRNAs potentially regulating the JAK-STAT signalling pathway.

Authors:  Beniamin O Grabarek; Dominika Wcisło-Dziadecka; Joanna Gola
Journal:  Postepy Dermatol Alergol       Date:  2020-09-02       Impact factor: 1.837

Review 2.  Trials with 'epigenetic' drugs: an update.

Authors:  Angela Nebbioso; Vincenzo Carafa; Rosaria Benedetti; Lucia Altucci
Journal:  Mol Oncol       Date:  2012-10-06       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.